83 related articles for article (PubMed ID: 27458061)
1. Human hemokinin-1 promotes migration of melanoma cells and increases MMP-2 and MT1-MMP expression by activating tumor cell NK1 receptors.
Zhang Y; Li X; Li J; Hu H; Miao X; Song X; Yang W; Zeng Q; Mou L; Wang R
Peptides; 2016 Sep; 83():8-15. PubMed ID: 27458061
[TBL] [Abstract][Full Text] [Related]
2. Neurokinin-1 receptor mediated breast cancer cell migration by increased expression of MMP-2 and MMP-14.
Li J; Zeng Q; Zhang Y; Li X; Hu H; Miao X; Yang W; Zhang W; Song X; Mou L; Wang R
Eur J Cell Biol; 2016 Oct; 95(10):368-377. PubMed ID: 27498853
[TBL] [Abstract][Full Text] [Related]
3. Neurokinin-1 receptor directly mediates glioma cell migration by up-regulation of matrix metalloproteinase-2 (MMP-2) and membrane type 1-matrix metalloproteinase (MT1-MMP).
Mou L; Kang Y; Zhou Y; Zeng Q; Song H; Wang R
J Biol Chem; 2013 Jan; 288(1):306-18. PubMed ID: 23166329
[TBL] [Abstract][Full Text] [Related]
4. The N-terminal domain of human hemokinin-1 influences functional selectivity property for tachykinin receptor neurokinin-1.
Mou L; Xing Y; Kong Z; Zhou Y; Chen Z; Wang R
Biochem Pharmacol; 2011 Mar; 81(5):661-8. PubMed ID: 21168392
[TBL] [Abstract][Full Text] [Related]
5. Expression and proliferative effect of hemokinin-1 in human B-cells.
Grassin-Delyle S; Buenestado A; Vallat L; Naline E; Marx S; Decocq J; Debré P; Bernard OA; Advenier C; Devillier P; Merle-Béral H
Peptides; 2011 May; 32(5):1027-34. PubMed ID: 21334411
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronan-binding protein 1 (HABP1/p32/gC1qR) induces melanoma cell migration and tumor growth by NF-kappa B dependent MMP-2 activation through integrin α(v)β(3) interaction.
Prakash M; Kale S; Ghosh I; Kundu GC; Datta K
Cell Signal; 2011 Oct; 23(10):1563-77. PubMed ID: 21627988
[TBL] [Abstract][Full Text] [Related]
7. MT1-MMP dependent repression of the tumor suppressor SPRY4 contributes to MT1-MMP driven melanoma cell motility.
Shaverdashvili K; Zhang K; Osman I; Honda K; Jobava R; Bedogni B
Oncotarget; 2015 Oct; 6(32):33512-22. PubMed ID: 26392417
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of the tachykinins substance P/neurokinin A/hemokinin-1 and their preferred neurokinin 1/neurokinin 2 receptors in uterine leiomyomata.
González-Santana A; Marrero-Hernández S; Dorta I; Hernández M; Pinto FM; Báez D; Bello AR; Candenas L; Almeida TA
Fertil Steril; 2016 Nov; 106(6):1521-1529. PubMed ID: 27456549
[TBL] [Abstract][Full Text] [Related]
9. β-Elemene inhibits the metastasis of B16F10 melanoma cells by downregulation of the expression of uPA, uPAR, MMP-2, and MMP-9.
Shi H; Liu L; Liu L; Geng J; Zhou Y; Chen L
Melanoma Res; 2014 Apr; 24(2):99-107. PubMed ID: 24535052
[TBL] [Abstract][Full Text] [Related]
10. Role of β-catenin signaling in the anti-invasive effect of the omega-3 fatty acid DHA in human melanoma cells.
Serini S; Zinzi A; Ottes Vasconcelos R; Fasano E; Riillo MG; Celleno L; Trombino S; Cassano R; Calviello G
J Dermatol Sci; 2016 Nov; 84(2):149-159. PubMed ID: 27600927
[TBL] [Abstract][Full Text] [Related]
11. Benzyl isothiocyanate and phenethyl isothiocyanate inhibit murine melanoma B16F10 cell migration and invasion in vitro.
Lai KC; Hsiao YT; Yang JL; Ma YS; Huang YP; Chiang TA; Chung JG
Int J Oncol; 2017 Sep; 51(3):832-840. PubMed ID: 28766686
[TBL] [Abstract][Full Text] [Related]
12. The tachykinin NK1 receptor. Part I: ligands and mechanisms of cellular activation.
Quartara L; Maggi CA
Neuropeptides; 1997 Dec; 31(6):537-63. PubMed ID: 9574822
[TBL] [Abstract][Full Text] [Related]
13. ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells.
Zhong J; Gencay MM; Bubendorf L; Burgess JK; Parson H; Robinson BW; Tamm M; Black JL; Roth M
J Cell Physiol; 2006 May; 207(2):540-52. PubMed ID: 16447244
[TBL] [Abstract][Full Text] [Related]
14. MT1-MMP modulates melanoma cell dissemination and metastasis through activation of MMP2 and RAC1.
Shaverdashvili K; Wong P; Ma J; Zhang K; Osman I; Bedogni B
Pigment Cell Melanoma Res; 2014 Mar; 27(2):287-96. PubMed ID: 24387669
[TBL] [Abstract][Full Text] [Related]
15. Expression and function of human hemokinin-1 in human and guinea pig airways.
Grassin-Delyle S; Naline E; Buenestado A; Risse PA; Sage E; Advenier C; Devillier P
Respir Res; 2010 Oct; 11(1):139. PubMed ID: 20929541
[TBL] [Abstract][Full Text] [Related]
16. Kinetic binding and activation profiles of endogenous tachykinins targeting the NK1 receptor.
Nederpelt I; Bleeker D; Tuijt B; IJzerman AP; Heitman LH
Biochem Pharmacol; 2016 Oct; 118():88-95. PubMed ID: 27501920
[TBL] [Abstract][Full Text] [Related]
17. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
18. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration.
Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS
Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740
[TBL] [Abstract][Full Text] [Related]
19. A novel matrix metalloproteinase-2 inhibitor triazolylmethyl aziridine reduces melanoma cell invasion, angiogenesis and targets ERK1/2 phosphorylation.
Romanchikova N; Trapencieris P; Zemītis J; Turks M
J Enzyme Inhib Med Chem; 2014 Dec; 29(6):765-72. PubMed ID: 24246091
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta induces CD44 cleavage that promotes migration of MDA-MB-435s cells through the up-regulation of membrane type 1-matrix metalloproteinase.
Kuo YC; Su CH; Liu CY; Chen TH; Chen CP; Wang HS
Int J Cancer; 2009 Jun; 124(11):2568-76. PubMed ID: 19243022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
